Pfizer gives vaccine data from kids 5-12 to FDA

  • Dr. Peter Marks, director of the Center for Biologics Evaluation and Research in the Food and Drug Administration, urged parents to be patient, saying the agency will rapidly evaluate vaccines for 5- to 11-year-olds as soon as it gets the needed data. (JIM LO SCALZO/Associated Press)
    Dr. Peter Marks, director of the Center for Biologics Evaluation and Research in the Food and Drug Administration, urged parents to be patient, saying the agency will rapidly evaluate vaccines for 5- to 11-year-olds as soon as it gets the needed data. (JIM LO SCALZO/Associated Press)
    NEW YORK — Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its covid-19 vaccine in children as it moves closer to seeking approval for expanded use ...

    Premium Content is available to subscribers only. Please login here to access content or go here to purchase a subscription.